Odelia B. Cooper, MD

Associate Professor, Medicine

Cedars-Sinai Pituitary Center
127 S. San Vicente Blvd.
Advanced Health Sciences Pavilion, Suite A6600
Los Angeles, CA 90048





Diabetes Outpatient Treatment and Education Center
8723 Alden Drive
Steven Spielberg Building, Suite 250
Los Angeles, CA 90048





Odelia B. Cooper, MD

Associate Professor, Medicine

  • IM/Endocrinology
  • Pituitary


Adrenal Gland Disorders

Adrenal Hypertension

Calcium Disorders

Cushing's Disease

Diabetes Mellitus (Type 1 & 2)

Growth Hormone Deficiency




Insulin Pump Therapy

Osteoporosis General

Parathyroid Disorders

Pituitary Disorders

Pituitary Tumors


Thyroid Cancers

Thyroid Disorders

The research of Odelia B. Cooper, MD, focuses on pituitary tumors, with the goal of understanding signaling pathways contributing to pituitary tumorigenesis in order to develop new therapies targeting recurrent tumor growth and invasion. Based on her work on a rare subset of aggressive tumors, Cooper began to investigate mechanisms by which pituitary tumors progress from noninvasive to invasive behavior. This led to her interest in the ErbB pathway to see if these receptors play an active role in pituitary tumorigenesis. Cooper is now validating clinical response of patients with aggressive tumors to ErbB targeted therapy.

  • Undergraduate: Johns Hopkins University, 1998
  • Medical School: Johns Hopkins University School of Medicine, 2002
  • Residency: Cedars-Sinai, 2006
  • Fellowship: Cedars-Sinai, 2008
  • Fellowship: Cedars-Sinai, 2009
  • K23 Career Development Award, National Institutes of Health
  • Member, Endocrine Society and Pituitary Society
  • Outstanding PBL Tutor Award, UCLA
  • R21 Grant, National Institute of Diabetes and Digestive and Kidney Diseases
  • Schell MJ, Cooper OB, Snyder SH. D-aspartate localizations imply neuronal and neuroendocrine roles. Proc Natl Acad Sci USA. 1997;(5):2013-2018.
  • Cooper O, Geller JL, Melmed S. Ovarian hyperstimulation syndrome caused by an FSH-secreting pituitary adenoma. Nat Clin Pract Endocrinol Metab. 2008;(4):234-238.
  • Vlotides G, Cooper O, Chen YH, Ren SG, Greenman Y, Melmed S. Heregulin regulates prolactinoma gene expression. Cancer Res. 2009;(10):4209-4216.
  • Cooper O, Vlotides G, Fukuoka H, Greene MI, Melmed S. Expression and function of ErbB receptors and ligands in the pituitary. Endocr Relat Cancer. 2011;18(6):R197-R211.
  • Cooper O, Ben-Shlomo A, Bonert V, Bannykh S, Mirocha J, Melmed S. Silent corticogonadotroph adenomas: clinical and cellular characteristics and long term outcomes. Horm Cancer. 2010;1(1):80-92.
  • Cooper O, Mamelak A, Bannykh S, Carmichael JD, Bonert V, Lim S, Cook-Wiens G, Ben-Shlomo A. Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors. Endocrine. 2014;46(2):318-327.

Show moreShow less


Make an Appointment




Available 24 Hours A Day


Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.

Send Email to Odelia B. Cooper, MD